Corteva (NYSE:CTVA – Free Report) had its price objective upped by Royal Bank of Canada from $68.00 to $73.00 in a report issued on Thursday morning,Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock.
Other equities analysts have also recently issued reports about the company. KeyCorp raised their price objective on Corteva from $66.00 to $69.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. UBS Group lifted their price target on shares of Corteva from $67.00 to $71.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Barclays increased their price objective on shares of Corteva from $58.00 to $62.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Morgan Stanley restated an “overweight” rating and issued a $65.00 target price on shares of Corteva in a research note on Tuesday, September 24th. Finally, Wells Fargo & Company increased their price target on Corteva from $65.00 to $67.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus target price of $65.41.
View Our Latest Research Report on Corteva
Corteva Trading Down 0.4 %
Corteva declared that its Board of Directors has authorized a stock buyback plan on Tuesday, November 19th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the company to reacquire up to 7.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.
Corteva Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Monday, December 2nd were paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.21%. The ex-dividend date of this dividend was Monday, December 2nd. Corteva’s payout ratio is currently 68.69%.
Institutional Investors Weigh In On Corteva
Large investors have recently modified their holdings of the stock. KBC Group NV boosted its position in shares of Corteva by 267.3% in the 3rd quarter. KBC Group NV now owns 1,120,104 shares of the company’s stock valued at $65,851,000 after purchasing an additional 815,135 shares during the period. Charles Schwab Investment Management Inc. grew its position in Corteva by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,523,996 shares of the company’s stock worth $265,966,000 after purchasing an additional 66,052 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in shares of Corteva by 16.1% in the third quarter. Thrivent Financial for Lutherans now owns 1,025,266 shares of the company’s stock worth $60,275,000 after buying an additional 141,898 shares during the period. Kingsview Wealth Management LLC grew its holdings in shares of Corteva by 468.8% during the third quarter. Kingsview Wealth Management LLC now owns 45,182 shares of the company’s stock valued at $2,656,000 after buying an additional 37,239 shares in the last quarter. Finally, Nisa Investment Advisors LLC lifted its stake in Corteva by 0.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 220,134 shares of the company’s stock worth $12,942,000 after acquiring an additional 845 shares in the last quarter. 81.54% of the stock is owned by institutional investors.
Corteva Company Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Further Reading
- Five stocks we like better than Corteva
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Beyond Reality: Investing in AR/VR Tech for Future Gains
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Palantir’s Momentum Persists Despite Market Worries
- 10 Best Airline Stocks to Buy
- Ad Sales to Top $1 Trillion: 3 Stocks to Take Advantage
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.